EUQ.F Eurazeo SE
- Market cap
- EUR 3.13B
- P/E
- -
- P/B
- 0.53x
- ROE
- -6.5%
- Dividend yield
- 6.03%
- Fundamental score
- -
Ratios use the latest price and the fiscal year ending Dec 2025.
Is EUQ.F undervalued?
Graham numberThe Graham number of Eurazeo SE cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Eurazeo SE fundamental analysis
No fundamental analysis for Eurazeo SE yet.
Eurazeo SE stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Eurazeo SE
Eurazeo SE is a private equity and venture capital firm specializing in growth capital, series C, acquisitions, leveraged buyouts, and buy-ins of a private company, and investments in upper mid-market, mid-market and listed public companies, small- and mid-cap healthcare companies, equity in the small-mid and mid-large buyout segments. The firm seeks to invest in medium-sized or large companies, SMEs, high growth companies, and real estate management and investment activitie…
Full company profileEurazeo SE financial statements
Eurazeo SE annual financial statements (EUR; K = thousand, M = million, B = billion, T = trillion)
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||||
| Revenue | 2.18B | 3.48B | 4.37B | 4.68B | 3.66B | 6.15B | 5.54B | 344M | 383M | 416M |
| Gross Profit | 909M | 1.34B | 1.52B | 1.74B | 1.40B | 3.52B | 2.88B | 122M | 148M | 173M |
| Operating Income | 157M | 135M | 47.4M | 150M | 217M | 2.23B | 1.07B | 74.9M | -348M | -332M |
| EBITDA | - | 853M | 913M | 841M | 886M | 2.76B | 1.40B | 1.94B | -311M | -321M |
| Net Income | 520M | 441M | 251M | 123M | -160M | 1.58B | 595M | 1.82B | -430M | -403M |
| EPS | - | 6.06 | 3.29 | 1.61 | -2.10 | 21 | 7.85 | 25 | -6.07 | -6.20 |
| Balance Sheet | ||||||||||
| Total Assets | 10.4B | 11.5B | 12.0B | 13.9B | 13.8B | 16.1B | 18.9B | 9.77B | 9.42B | 8.19B |
| Total Liabilities | 5.14B | 6.03B | 5.74B | 7.26B | 7.74B | 7.74B | 9.57B | 1.41B | 1.87B | 1.70B |
| Shareholders' Equity | 4.49B | 4.72B | 5.08B | 5.02B | 4.66B | 6.16B | 6.48B | 8.10B | 7.26B | 6.25B |
| Cash & Short-term Investments | 1.50B | 872M | 935M | 1.07B | 1.13B | 1.33B | 1.01B | 109M | 82.8M | 107M |
| Cash Flow | ||||||||||
| Operating Cash Flow | 138M | 196M | 242M | 480M | 301M | 316M | 254M | -11.6M | 68.9M | 126M |
| Capital Expenditure | 551M | 145M | 180M | 228M | 171M | 157M | 366M | 12.6M | 18.2M | 5.07M |
| Free Cash Flow | - | -5.66M | -7.91M | 197M | 68.6M | 56.7M | -191M | -24.2M | 50.7M | 121M |
| Ratios | ||||||||||
| ROE | 11.6% | 9.3% | 4.9% | 2.5% | -3.4% | 25.6% | 9.2% | 22.5% | -5.9% | -6.5% |
| ROA | 5.0% | 3.8% | 2.1% | 0.9% | -1.2% | 9.8% | 3.2% | 18.7% | -4.6% | -4.9% |
| Net Profit Margin | 23.8% | 12.7% | 5.7% | 2.6% | -4.4% | 25.6% | 10.7% | 530.8% | -112.1% | -97.0% |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
Eurazeo SE dividends
- Dividend yield
- 6.03%
- Forward dividend
- 2.92 EUR
- Payout ratio
- -
- Ex-dividend date
- May 18, 2026
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2025 | EUR 189M | 2.90 | - |
| 2024 | EUR 179M | 2.52 | - |
| 2023 | EUR 168M | 2.29 | 9.2% |
| 2022 | EUR 231M | 3.05 | 38.8% |
| 2021 | EUR 115M | 1.50 | 7.3% |
| 2020 | EUR 115M | 1.51 | - |
| 2019 | EUR 91.6M | 1.20 | 74.5% |
| 2018 | EUR 89.8M | 1.18 | 35.8% |
| 2017 | EUR 78.7M | 1.08 | 17.9% |
| 2016 | EUR 159M | - | 30.7% |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Last stock split: 21:20 on May 9, 2019.
Who owns Eurazeo SE
- Insiders 43.67%
- Institutions 10.91%
- Public & others 45.41%
- Shares outstanding 63.0M
- Free float 35.5M
Eurazeo SE company profile
- Company name
- Eurazeo SE
- Ticker
- EUQ.F
- ISIN
- FR0000121121
- Exchange
- Frankfurt Exchange
- Sector
- Financial Services
- Industry
- Capital Markets
- Employees
- 451
- Fiscal year end
- December
- Address
- 66 rue Pierre Charron, Paris, France, 75008
- Phone
- 33 (0) 1 44 15 01 11
- Website
- eurazeo.com/en
About Eurazeo SE
Eurazeo SE is a private equity and venture capital firm specializing in growth capital, series C, acquisitions, leveraged buyouts, and buy-ins of a private company, and investments in upper mid-market, mid-market and listed public companies, small- and mid-cap healthcare companies, equity in the small-mid and mid-large buyout segments. The firm seeks to invest in medium-sized or large companies, SMEs, high growth companies, and real estate management and investment activities. It does not have any restrictions regarding the sectors in which it invests but prefers to invest in smart cities, services, leisure and mobility, real estate, fintech, investment activities, distribution, industry, luxury, consumer goods, business services, consumer and retail brands, and health sectors. The firm seeks to invest in consumer brands with a focus on beauty, digital health, life science, tech, financial services, personal care, household care, juvenile products, apparel, wellness, accessories, home, jewellery, leisure, health, fitness, beverage, and food companies based in United States and Europe. It typically invests in companies with a differentiated concept and global growth potential. The firm identifies companies upstream, carefully selecting them primarily from sectors driven by digital transformation and focusing on changes in lifestyle and consumption (mobility, online buying, collaboration models, etc. The firm invests in large properties in need of restructuring; residential, commercial, and office development projects; and companies with real estate assets in Western Europe. It primarily invests in New York, United States, Paris, France, Italy, North America, China and other European countries. It seeks to invest between "50 million ($54.35 million) to "250 million ($271.77 million) in small mid buyout business. It seeks to invest between "25 million ($27.18 million) and"100 million ($108.71 million) in growth business. It seeks to invest between "10 million ($10.82 million) and "40 million ($43.82 million) in the
Eurazeo SE management
10- Ms. Sophie FlakMember of Executive Board & Managing Partner of Sustainability & Impact · born 1972
- Mr. Remi VielManaging Director of Capital
- Ms. Maud GillotManaging Director of Growth
- Mr. Alexandre BretManaging Director of Elevate
- Ms. Melissa CohenManaging Partner & Co-Head Infrastructure
- Mr. Laurent ChatelinManaging Partner & Co-Head Infrastructure
- Ms. Laurence BranthommeCFO & Head of Operations
- Mr. Arnaud BertheManaging Director of Group Accounting
- Ms. Valérie DucourtyMD of Corporate & Flex Financing · born 1973
- Mr. Jean-Daniel VouilleChief Technical Officer